Establishment of an experimental breast cancer ZHENG model and curative effect evaluation of Zuo-Jin Wan

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Du, Jia ^a   Sun, Yang ^a   Wang, Xiu Feng ^a   Lu, Yi Yu ^a   Zhou, Qian Mei ^a   Su, Shi Bing ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893744550     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/324732     Document Type: Article

References (28)

1. Ferlay J., Shin H. R., Bray F., GLOBOCAN, 2008 V1. 2, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10 [Internet] 2010 Lyon, France International Agency for Research on Cancer. http://globocan.iarc.fr/
2. Yang L., Li L., Chen Y., Parkin D. M., Cancer incidence and mortality estimates and prediction for year 2000 and 2005 in China. Chinese Journal of Health Statistics 2005 22 4 218 222
3. He Y., Zheng X., Sit C., Using association rules mining to explore pattern of Chinese medicinal formulae (prescription) in treating and preventing breast cancer recurrence and metastasis. Journal of Translational Medicine 2012 10 supplement 1 S12 10.1186/1479-5876-10-S1-S12
4. Chen Z., Chen L. Y., Wang P., Tumor microenvironment varies under different TCM ZHENG models and correlates with treatment response to herbal medicine. Evidence-Based Complementary and Alternative Medicine 2012 2012 10 635702 10.1155/2012/635702
5. Tang Q. F., Liu X., Ge Y., Experimental study on inhibiting proliferation and inducing apoptosis of zuo jin wan alcohol extracts on human gastric cancer cells infected by Helicobacter pylori. Chongqing Medicine 2012 41 15 1462 1464
6. Chao D. C., Lin L. J., Kao S. T., Huang H., Chang C., Liang J., Wu S., Hsiang C., Ho T., Inhibitory effects of Zuo-Jin-Wan and its alkaloidal ingredients on activator protein 1, nuclear factor- B, and cellular transformation in HepG2 cells. Fitoterapia 2011 82 4 696 703 2-s2.0-79955478204 10.1016/j.fitote.2011.02.009
7. Sui H., Liu X., Jin B. H., Zuo Jin Wan, a traditional Chinese herbal formula, reverses P-gp-mediated MDR in vitro and in vivo. Evidence-Based Complementary and Alternative Medicine 2013 2013 13 957078 10.1155/2013/957078
8. Xu, Qi Y., Lv L., In vitro anti-proliferative effects of Zuojinwan on eight kinds of human cancer cell lines. Cytotechnology 2013
9. Fang Z. Q., Pan Z. Q., Xu W. L., Methodology and purposes of establishing mouse and rat models for syndrome differentiation and treatment. Zhong Xi Yi Jie He Xue Bao 2009 7 10 907 912
10. Zheng X., Guideline for Clinical New Drug Research in Chinese Herbal Medicine 2002 5 Beijing, China Chinese Medical Science and Technology Press
11. Song Y. N., Sun J. J., Lu Y. Y., Therapeutic efficacy of Fuzheng-Huayu tablet based traditional Chinese medicine syndrome differentiation on hepatitis-B-caused cirrhosis: a multicenter double-blind randomized controlled trail. Evidence-Based Complementary and Alternative Medicine 2013 2013 8 709305 10.1155/2013/709305
12. Su S. B., Recent advance in ZHENG differentiation research in traditional Chinese medicine. International Journal of Integrative Medicine 2013 1 7 2013
13. Chai C., Kou J., Zhu D., Mice exposed to chronic intermittent hypoxia simulate clinical features of deficiency of both Qi and Yin syndrome in traditional Chinese medicine. Evidence-Based Complementary and Alternative Medicine 2011 2011 7 356252 10. 1093/ecam/nep226
14. Dai H. Y., Wang P., Feng L., Liu L., Meng Z., Zhu X., Kun Wang K. W., Hua Y., Mao Y., Chen L., Chen Z., The molecular mechanisms of traditional Chinese medicine ZHENG syndromes on pancreatic tumor growth. Integrative Cancer Therapies 2010 9 3 291 297 2-s2.0-78649913431 10.1177/1534735410373922
15. Miller R. P., Tadagavadi R. K., Ramesh G., Reeves W. B., Mechanisms of cisplatin nephrotoxicity. Toxins 2010 2 11 2490 2518 2-s2.0-79952142018 10.3390/toxins2112490
16. Boulikas T., Clinical overview on Lipoplatin ™: a successful liposomal formulation of cisplatin. Expert Opinion on Investigational Drugs 2009 18 8 1197 1218 2-s2.0-68049142557 10.1517/13543780903114168
17. McWhinney S. R., Goldberg R. M., McLeod H. L., Platinum neurotoxicity pharmacogenetics. Molecular Cancer Therapeutics 2009 8 1 10 16 2-s2.0-58149484793 10.1158/1535-7163.MCT-08-0840
18. Cohen I., Tagliaferri M., Tripathy D., Traditional Chinese medicine in the treatment of breast cancer. Seminars in Oncology 2002 29 6 563 574 2-s2.0-0036969688 10.1053/sonc.2002.50005 (Pubitemid 36134979)
19. Mukherjee A. K., Basu S., Sarkar N., Ghosh A. C., Advances in cancer therapy with plant based natural products. Current Medicinal Chemistry 2001 8 12 1467 1486 2-s2.0-0034831086 (Pubitemid 32894010)
20. Hsiao W. L., Liu L., The role of traditional Chinese herbal medicines in cancer therapy from TCM theory to mechanistic insights. Planta Medica 2010 76 11 1118 1131 2-s2.0-77955058763 10.1055/s-0030-1250186
21. Wang X. F., Du J., Zhang T. L., Inhibitory effects of PC-SPESII herbal extract on human breast cancer metastasis. Evidence-Based Complementary and Alternative Medicine 2013 2013 11 894386 10.1155/2013/894386
22. Zhao F.-R., Mao H.-P., Zhang H., Hu L.-M., Wang H., Wang Y.-F., Yanagihara N., Gao X.-M., Antagonistic effects of two herbs in Zuojin Wan, a traditional Chinese medicine formula, on catecholamine secretion in bovine adrenal medullary cells. Phytomedicine 2010 17 8-9 659 668 2-s2.0-77952290891 10.1016/j.phymed.2009.10.010
23. Wang X., Xu L., Peng J., Liu K., Zhang L., Zhang Y., In vivo inhibition of s180 tumors by the synergistic effect of the chinese medicinal herbs coptis chinensis and evodia rutaecarpa. Planta Medica 2009 75 11 1215 1220 2-s2.0-70350757629 10.1055/s-0029-1185538
24. Wang X. N., Han X., Xu L.-N., Yin L.-H., Xu Y.-W., Qi Y., Peng J.-Y., Enhancement of apoptosis of human hepatocellular carcinoma SMMC-7721 cells through synergy of berberine and evodiamine. Phytomedicine 2008 15 12 1062 1068 2-s2.0-56349149424 10.1016/j.phymed.2008.05.002
25. Yang J., Wu L., Tashino S., Onodera S., Ikejima T., Critical roles of reactive oxygen species in mitochondrial permeability transition in mediating evodiamine-induced human melanoma A375-S2 cell apoptosis. Free Radical Research 2007 41 10 1099 1108 2-s2.0-34748824207 10.1080/10715760701499356 (Pubitemid 47470847)
26. Yang Z. G., Chen A. Q., Liu B., Antiproliferation and apoptosis induced by evodiamine in human colorectal carcinoma cells (COLO-205). Chemistry and Biodiversity 2009 6 6 924 933 2-s2.0-67650156103 10.1002/cbdv.200800256
27. Wang Q., Cui Y., Dong T., Zhang X., Lin K., Ethanol extract from a Chinese herbal formula, "zuojin Pill" inhibit the expression of inflammatory mediators in lipopolysaccharide- stimulated RAW 264.7 mouse macrophages. Journal of Ethnopharmacology 2012 141 1 377 385 2-s2.0-84859761800 10.1016/j.jep.2012.02.049
28. Wang Q. S., Ding S. L., Mao H. P., Antidepressant-like effect of ethanol extract from Zuojin Pill, containing two herbal drugs of Rhizoma Coptidis and Fructus Evodiae, is explained by modulating the monoaminergic neurotransmitter system in mice. Journal of Ethnopharmacology 2013 148 2 603 609